ProCE Banner Activity

Considerations in Selecting Therapy for Previously Treated CLL

Conference Coverage
Slideset

Download this slideset from a live symposium at ASH 2023 for expert perspectives on best practices in treating patients with relapsed/refractory CLL.

Released: December 06, 2023

Share

Faculty

Deborah Stephens

Deborah Stephens, DO

Associate Professor
Director of the CLL Program
Lineberger Comprehensive Cancer Center
University of North Carolina
Chapel Hill, North Carolina

Provided by

Provided by the National Comprehensive Cancer Network (NCCN) in partnership with Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, BeiGene, Ltd., and Lilly.

AstraZeneca

BeiGene Ltd

Lilly

Partners

Clinical Care Options, LLC

ProCE Banner